Potential Therapy Discovered For Hypophosphatasia, A Congenital Form Of Rickets
Tuesday, June 3, 2008 - 16:14
in Health & Medicine
Researchers have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia, a primary skeletal disease of genetic origin. This discovery lays the foundation for future clinical trials for HPP patients.